We would love to hear your thoughts about our site and services, please take our survey here.
Good to see a mention of @versarien in today�s London Evening Standard. Not sure I�d call �150m MC a �tiddler� - except in relation to where VRS should be in a year or two... @neillricketts @SharePickers
glad your ok, thought you might have collapsed on your send button and no one knew.
29-Jan-18 Exercise of option Trade Notifier Information for Versarien Neill Gareth Ricketts 12.25 GBX 278,720 15653720
Theresa to return from China with 9bn's worth of trade. Let's hope if she does some of it heads ITM's way one way or another.
I do not know enough to say, suggest you ask ITM.
Was that question and answer session for real? Showed a lack of intellectual quality on somebodys part for me. Or did I miss something?
Here is the list of all the business people and organisations travelling with Theresa May: Jane King, Chief Executive Officer, Agriculture & Horticulture Development Board (AHDB) Gregory Hodkinson, Chairman, Arup Dr Andy Palmer CMG, President & CEO, Aston Martin Lagonda Pascal Soriot, Chief Executive Officer, AstraZeneca Jessica Butcher MBE, Co-founder & Non Executive Director, Blippar Dev Sanyal, Chief Executive, Alternative Energy, and Executive Vice President, Regions, BP plc Caroline Wright, Director General, British Educational Suppliers Association Evelyn Bourke, Group CEO, Bupa John Woodward OBE, President & Founder, Busy Bees Nursery Group Jeanette Walker, Director, Cambridge Science Park Sir George Iacobescu CBE, Chairman & CEO, Canary Wharf Group plc Lord Sassoon, Chairman (and Executive Director, Jardine Matheson Holdings), China-Britain Business Council Carolyn Fairbairn, Director-General, Confederation of British Industry Joanna Lavan, Managing Director, ConnectChina Nick Carpenter, Owner & Engineering Director, Delta Motorsport David Harland, Chief Executive Eden Project International, Eden Project Dr Kevin Lindsey, Managing Director, Far-UK Conrad Ford, Chief Executive, Funding Options Dr George Gillespie OBE, CEO, HORIBA MIRA Mark E Tucker, Chairman, HSBC Holdings plc Stephen Martin, Director General, Institute of Directors Professor Dr Ralf Speth, CEO, Jaguar Land Rover Ross McMahon, CEO, Kendal Nutricare Sally Preston, Founder and Managing Director, Kiddylicious Nikhil Rathi, CEO, London Stock Exchange Group Dr Jens Ludmann, Chief Operating Officer, McLaren Automotive Dr Ian Hudson, CEO, Medicines and Healthcare Products Regulatory Agency (MHRA) Dan Vahdat, CEO, Medopad Brian McConville, Owner & Chairman, MJM Marine Andrew Henderson, Managing Director, NeMi Dairy Stuart Garner, CEO, Norton Motorcycles Robert McFarlane, Group Chairman & CEO, NPL Group Paul Priestman, Chairman, PriestmanGoode Jon Vollemaere, CEO, R5FX Hugo Spowers, Managing Director, Riversimple Movement Andrew Rooney, Managing Director, Rooney Fish Karen Betts, Chief Executive, Scotch Whisky Association Chris Fraser, CEO, Sirius Minerals Bill Winters CBE, Group Chief Executive, Standard Chartered Bank Sir Gerry Grimstone, Chairman, Standard Life Aberdeen plc Andrew Chaloner, CEO, Stream Bio Asher Bennett, CEO, Tevva Motors Professor Dame Nancy Rothwell, President & Vice-Chancellor, The University of Manchester Lesley Davies OBE, Chair, UK Skills Partnership Professor Dame Janet Beer, President (& Vice-Chancellor of the University of Liverpool), Universities UK Heba Bevan, Chief Executive Officer & Founder, UtterBerry Neill Ricketts, CEO, Versarien Mark Dunhill, CEO, Whittard of Chelsea Jonathan Quin, CEO and Co-Founder, WorldFirst Douglas Flint, Chancellor�s City Envoy to the Belt and Road Initiative Advertisement
Wouldn't recognise him if I bumped into him in the street. Think he has connections to the investment funding houses? Probably did what all of us did? Saw the potential and is still waiting but may have the resources that he can afford to wait. That is a guess.
That is "positive".
father, do want to get involved with the spat on your views, which are admirable and consistent, although I have a reserved agreement. But one thing we can agree on is (many times). I would invest further but feel my portfolio is reasonably balanced, so I remain more posotive. No offence intended on my part. ATB
Everyone knows it does what it says on the tin. Therefore can we have some clear clarity on where it has thusfar failed to deliver income. It is not a drug and so does not immediately fit the pharmaceutical industry. That will come hopefully. It is health beneficial, but only to anyone who has researched the need and options But mainly, it is expensive compared to drugs and expensive if you do not have a known need. Blame PXS and IF/DB as much as you like but the cost of manufacture etc must be a main obstacle to its future success. I would suggest convincing the appropriate, and selling, will take some time and maybe too long? Discuss.
Neilos, you should have figured by now that listening to Crackup or whatever his handle is daft. He/She appeared a couple of weeks ago and it took me a couple of days to filter him/her so I never have to read those posts anymore.
I understand where you are coming from Neilos, but, if you follow your pattern of logic we may not have a stock market. As for Motley, well putting your life in those hands is probably a significant risk. It is well considering for those that have been here since the days of 20/40p it is a good time to take your profit and leave your original stake to run with it.
Good find Temple. Found under a toadstool no doubt. Tick up anyway.
Well, concrete, glass, plastic, aspirin, rubber etc etc were all new once with a market unknown. That is where we are with graphene. You have to decide if you see a future in it or not. If you do, I would invest, if you do not or remain unsure I suggest try something else. No end of talk on here should overly influence your decision. Look into the companies involved and the possibilities for the product. Sergio Garcisa is happier, he now hits the graphene ball 17 yards further on average. Maybe invest in golf balls?
Thnx. I could not copy the link myself for some reason. Probably fat finger or something like that. Old age etc.
Might have to look this up yourselves and do your own research, but worth it. Could not post link, sorry. @singularityhub 23h23 hours ago More How Graphene Research Is Taking Aim at 5 of the World�s Biggest Proble
Twitter earlier today. 2050-Capital‏ @2050Capital 1h1 hour ago Reflecting on #VRS upward move and @SharePickers comments on @VoxPodcast w/end podcast and you just simply can't apply traditional valuation metrics to an unknown material like Graphene. I see momentum upwards above �250m m/cap...
Vanilla, your posting history is important as is everyones equally. Why you should suddenly appear here and put yourself in the firing line is beyond me when your previous does not stand up. You said 300 by end of 2017 and now you want to extend it because it didn't. Go figure.
Predicted BOO would go to 300 by end of 2017 in Sept. It is 188 today. Check your own posting history. And by the way; Goodbye